7.920USD+2.33%Mkt Cap: 1.37B $P/E: 113.141d ago
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-u…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
P/B
Pricier
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap1.37B $
Enterprise Value1.51B $
Revenue (TTM)314.85M $
Gross Profit249.28M $
Net Income (TTM)554.00K $
Revenue/Share1.909 USD
Last Price7.920 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees435
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS98422E1038
Valuation
P/E (Trailing)113.14
P/E (Forward)20.05
PEG—
EV/EBITDA31.49
EV/Revenue4.81
P/S4.34
P/B96.59
EPS (TTM)0.07
EPS (Forward)0.40
52W Range
4.52061% of range10.08
52W High10.08 USD
52W Low4.520 USD
Profitability
Gross Margin85.41%
Oper. Margin9.52%
EBITDA Margin15.27%
Profit Margin0.19%
ROE4.05%
ROA0.14%
Growth
Revenue Growth38.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF28.63M $
CapEx (TTM)696.00K $
FCF Margin13.40%
FCF Yield3.09%
Net Debt146.80M $
Net Debt/EBITDA3.05
Balance Sheet
Debt/Equity18.85
Current Ratio2.12
Quick Ratio1.42
Book Value/Sh0.0820 USD
Cash/Share0.6470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.29 USD
Upside (mean)+42.5%
Target Range8.000 USD – 18.00 USD
$8.000+42.5% to mean$18.00
# Analysts7
Ownership
Shares Out.172.64M
Float166.69M
Insiders3.38%
Institutions62.38%
Short Interest
Short Ratio8.2d
Short % Float7.68%
Short % Out.7.42%
Shares Short12.81M
Short (prev mo.)12.36M
Technical
SMA 506.437 (+23.0%)
SMA 2007.029 (+12.7%)
Beta0.90
S&P 52W Chg20.05%
Avg Vol (30d)1.61M
Avg Vol (10d)2.38M
Technical Indicators
RSI (14)79.7
MACD0.3834
MACD Signal0.2767
MACD Hist.+0.1067
BB Upper8.033 USD
BB Middle6.863 USD
BB Lower5.693 USD
BB Width34.09%
ATR (14)0.2639 USD
Vol Ratio (20d)1.17x